Dose Response of Intravenous Sincalide(CCK-8) for Gallbladder Emptying
| Status: | Recruiting |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/2/2016 |
| Start Date: | May 2008 |
| Contact: | Alan H Maurer, MD |
| Email: | amaurer@temple.edu |
| Phone: | 215-707-8269 |
Dose Response of Intravenous Sincalide (CCK-8) for Gallbladder Emptying
This is a clinical research study to establish normal values for the infusion of a synthetic
form of the hormone cholecystokinin(CCK-8) for gallbladder emptying. Cholecystokinin is
released from the small bowel to stimulate the pancreas and gallbladder to help digest and
absorb food. Some people have gallbladder problems and need to be tested with the synthetic
cholecystokinin ( Kinevac®, Bracco Diagnostics, Inc.). The aim of this study is to find out
how differing amounts and intravenous infusion times of CCK-8 affect gallbladder emptying.
The findings in normal subjects will be used to establish normal values that can then be
compared with patients with suspected gallbladder disease.
form of the hormone cholecystokinin(CCK-8) for gallbladder emptying. Cholecystokinin is
released from the small bowel to stimulate the pancreas and gallbladder to help digest and
absorb food. Some people have gallbladder problems and need to be tested with the synthetic
cholecystokinin ( Kinevac®, Bracco Diagnostics, Inc.). The aim of this study is to find out
how differing amounts and intravenous infusion times of CCK-8 affect gallbladder emptying.
The findings in normal subjects will be used to establish normal values that can then be
compared with patients with suspected gallbladder disease.
Inclusion Criteria:
1. Healthy males and females between ages 18-65 years of age with no gastrointestinal
disease as screened by the Mayo Clinic GI Disease Screening Questionnaire
2. Subjects with high probability for compliance and completion of the study
3. Normal liver function tests and amylase
4. Normal ultrasound of the gallbladder
Exclusion Criteria:
1. Prior GI surgery, excluding appendectomy
2. Surgery within the past 3 months
3. BMI > 35
4. Female of childbearing age who is not practicing birth control and/or is pregnant or
lactating. (Confirm with urine pregnancy test)
5. Cardiovascular, endocrine, renal, gastrointestinal, or other chronic disease likely
to affect motility. This includes diabetes, renal insufficiency, gastroesophageal
reflux disease, gastroparesis, irritable bowel syndrome, prior peptic ulcer disease.
6. GI symptoms such as heartburn, chest pain, dysphagia, abdominal pain, nausea,
vomiting, constipation, diarrhea.
We found this trial at
1
site
Temple University Hospital On January 18, 1892 a three-story house at 3403 North Broad Street...
Click here to add this to my saved trials
